Provided by Tiger Trade Technology Pte. Ltd.

Castle Biosciences, Inc.

32.33
+0.01000.03%
Post-market: 32.330.00000.00%16:15 EDT
Volume:201.93K
Turnover:6.51M
Market Cap:987.67M
PE:-49.42
High:32.94
Open:32.77
Low:31.71
Close:32.32
52wk High:44.28
52wk Low:17.72
Shares:30.55M
Float Shares:28.22M
Volume Ratio:0.91
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6542
EPS(LYR):-0.8334
ROE:-4.20%
ROA:-1.36%
PB:2.10
PE(LYR):-38.79

Loading ...

Castle Biosciences - Expects Positive Adj Ebitda for Q3, Q4, and Fy2026

THOMSON REUTERS
·
Jul 31

Castle Biosciences CEO Derek Maetzold Disposes of $202,507 in Common Shares

Reuters
·
Jul 30

SciBase CEO Pia Renaudin to Step Down as Board Launches Successor Search

Reuters
·
Jul 28

Castle Biosciences CEO Derek J. Maetzold Disposes of 550 Common Shares Worth $12,606‬‬

Reuters
·
Jul 17

Castle Biosciences Gets New York State Department of Health Approval of AdvanceAD-Tx Test

MT Newswires Live
·
Jul 15

Castle Biosciences Announces New York State Department of Health Approval of Its Advancead-tx™ Test

THOMSON REUTERS
·
Jul 15

Castle Biosciences Schedules Second-quarter Results Webcast

Reuters
·
Jul 09

Castle Biosciences COO Kristen Oelschlager Sells 8,586 Shares for $209,041.2

Reuters
·
Jul 07

Castle Biosciences Says Decisiondx-melanoma I31-slnb Beats MIA Nomogram in Prospective SLNB Risk Study

Reuters
·
Jun 26

Castle Biosciences Initiated at Buy by Roth Capital

Dow Jones
·
Jun 25

Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook

TIPRANKS
·
Jun 25

Castle Biosciences CFO Frank Stokes set for Houston Business Journal CFO Awards event

Reuters
·
Jun 23

Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal

THOMSON REUTERS
·
Jun 23

Castle Biosciences grants 204,925 inducement RSUs to 172 employees under 2022 plan

Reuters
·
Jun 19

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 19

Castle Biosciences COO Kristen Oelschlager sells 8,587 shares worth $177,230.77

Reuters
·
Jun 19

Castle Biosciences CEO Derek J. Maetzold reports disposal of common shares worth $43,371.58

Reuters
·
Jun 18

Castle Biosciences says TissueCypher Barrett’s esophagus test tops 100,000 orders

Reuters
·
Jun 16

SciBase, Castle Biosciences enroll first patient in DETECT-AD study testing EIS to predict atopic dermatitis flares

Reuters
·
Jun 10

Castle Biosciences CEO Derek Maetzold disposes of common shares worth $129,609.50

Reuters
·
Jun 04